NDC 83047-0010-10

Investigational obecabtagene autoleucel cell therapy dose at Memorial Hospital for Cancer and Allied Diseases

AI-generated description

How this description was generated

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

OBECABTAGENE AUTOLEUCEL INTRAVENOUS SUSPENSION (10 X 10^6 CELLS) FIRST INFUSION

New York, NY

See all hospitals reporting NDC 83047-0010-10 →

Pricing by billing methodology

Price type

How this price compares nationally

Memorial Hospital for Cancer and Allied Diseases’s median price of $367.4k is 32% below the median hospital's median price ($540.0k), higher than 28% of the 18 hospitals reporting NDC 83047-0010-10. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Dec 1, 2025

Compare to other hospitals

See Investigational obecabtagene autoleucel cell therapy dose pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.